Skip to main content

Closed

PMVP: PMV Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-94.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio11.14×

PMV Pharmaceuticals, Inc.

PMVPNASDAQ Global Select·USD·Closed

PMV Pharmaceuticals, Inc.

PMVPNASDAQ·USD·Closed

$1.11

−1.77%

$1.11

−$0.02 (1.77%)

52W Range

10thpctl

Volume

0.34×avg

Mkt Cap

59.20MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

10thpctl

Volume

0.34×avg

Market Cap

59.20MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings